By Sanchayaita Roy and Twesha Dikshit (Reuters) -European shares were unchanged on Friday, as losses in heavyweight ...

Oncologic Drugs Advisory Committee (ODAC) has voted against the benefit/risk profile of GSK’s Blenrep (belantamab mafodotin) just days before the drug’s Prescription Drug User Fee Act (PDUFA) date.

Despite the setback with the Oncologic Drugs Advisory Committee vote, GSK emphasizes the unmet need in multiple myeloma and ...

The U.S. FDA has approved a prefilled syringe presentation of GSK plc’s SHINGRIX for the prevention of shingles.

The FTSE 100 continues its winning streak, buoyed by positive corporate updates and investor optimism in the Bank of ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

An FDA advisory committee ruled in two separate votes that two belantamab mafodotin combination regimens should not be used in the proposed dosages for previously treated adult patients with ...

Stock prices in London closed higher on Friday, with markets maintaining the optimism that prevailed after US President ...

Imperial is one of twelve research organisations selected to deliver the Government’s £54 million fund to recruit the world’s top researchers.

The anemia treatment missed its main goal in a myelofibrosis study. Meanwhile, Blenrep's return to the U.S. market may have ...

Wirth reflected on the industry’s collaborative nature, emphasizing, “Partnership is one of our core values, and we pride ...

The provider of health, safety, hygiene and environmental consultancy and security solutions reported a pretax loss of GBP127,419 for the year to the end of March, swinging from a profit of GBP332,317 ...